Not All Bruton’s Tyrosine Kinase Inhibitors are Created Equal: Pharmacologic Insights into the Efficacy, Resistance, and Safety of Covalent and Non-covalent BTK Inhibitors. Can Hematol Today [Internet]. 20 mai 2026 [cité 21 mai 2026];5(s02):2–7. Disponible à: https://canadianhematologytoday.com/article/view/5-s02-Minotti